Because of the poor 5-year survival rate and prognosis of patients with late stage melanoma, PLA1A, in conjunction with S-100 and HMB-45, could serve as a novel marker to distinguish lymph node naive melanoma from melanoma metastasis49. This evidence concerns the gene PMEL and melanoma.